Lexicon Pharmaceuticals (LXRX) Q3 2024 Earnings

1AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.22
-0.2
-0.19
-0.17

Details

Expected EPS
-0.176985
Actual EPS
-0.17
Surprise EPS
0.01
Surprise Percent
+3.95%

Description

Lexicon Pharmaceuticals (LXRX) has reported earnings of -0.17 per share for Q3 2024.

0 Comments

Share your thoughts